Cabergoline and mitral valve disease Patient Reports February 09, 2010

Cabergoline Side Effects Report #4600814-9
Cabergoline side effect was reported by a Health Professional from on Feb 21, 2005. Male patient, 64 years of age, was diagnosed with parkinsonism and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve disease, mitral valve incompetence, pleural disorder . Cabergoline dosage: (6 MG), ORAL. During the same period patient was treated with PERGOLIDE, SINEMET, AMANTADINE. Patient recovered.

Cabergoline Side Effects Report #5127987-6
Cabergoline side effect was reported by a Physician from JAPAN on Sept 27, 2006. Male patient, 82 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve disease, aortic valve incompetence, blood pressure diastolic decreased, cardiac murmur, cardiomegaly, mitral valve disease, mitral valve incompetence, oedema peripheral, pulmonary congestion. Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4966139-7
Cabergoline side effect was reported by a Consumer or non-health professional from GERMANY on Mar 27, 2006. Female patient, 81 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic arteriosclerosis, aortic valve incompetence, aortic valve sclerosis, dilatation atrial, left ventricular failure, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with AMANTADINE, NACOM. Patient recovered.

Cabergoline Side Effects Report #4696141-4
Cabergoline side effect was reported by a Health Professional from on June 09, 2005. Female patient, 80 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve disease, aortic valve incompetence, blood pressure increased, body temperature decreased, cardiac failure congestive, echocardiogram abnormal, hyperphagia, mitral valve disease, mitral valve incompetence. Cabergoline dosage: 1 MG (1 MG, QD), ORAL. During the same period patient was treated with MADOPAR, SYMMETREL, MICARDIS, SELBEX, AMLODIPINE, MAGNESIUM OXIDE. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4696161-X
Cabergoline side effect was reported by a Pharmacist from on June 06, 2005. Male patient, 74 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: anuria, blood pressure decreased, cardiac failure, condition aggravated, depressed level of consciousness, interstitial lung disease, mitral valve disease, respiratory arrest, respiratory failure. Cabergoline dosage: unknown. During the same period patient was treated with DROXIDOPA, NEODOPASOL, DEPAS IETIZOLAM), NAUZELIN, LASIX, LANIRAID. Patient was hospitalized. Patient died on 05/10/2005.

Cabergoline Side Effects Report #4742129-4
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on July 25, 2005. Male patient, 68 years of age, weighting 194.0 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, fibrosis, mitral valve disease, mitral valve incompetence. Cabergoline dosage: 6 MG (EVERY DAY), ORAL. During the same period patient was treated with GLUCOSAMINE, AMANTADINE. Patient recovered.

Cabergoline Side Effects Report #5472014-4
Cabergoline side effect was reported by a Health Professional from UNITED KINGDOM on Sept 17, 2007. Female patient, 65 years of age, was diagnosed with parkinson's disease , blood cholesterol increased, dyspnoea, gastrointestinal disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve disease, pulmonary fibrosis , pulmonary hypertension . Cabergoline dosage: unknown. During the same period patient was treated with ATORVASTATIN CALCIUM, BUMETANIDE, OMEPRAZOLE, TRIHEXYPHENIDYL. Patient recovered.

Cabergoline Side Effects Report #5474726-5
Cabergoline side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 14, 2007. Female patient, 65 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve disease, pulmonary fibrosis , pulmonary hypertension . Cabergoline dosage: 4 MG (4 MG, 1 IN 1 D) ORAL. Patient recovered.

Cabergoline Side Effects Report #5150896-3
Cabergoline side effect was reported by a Physician from JAPAN on Oct 26, 2006. Female patient, 63 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve calcification, aortic valve incompetence, blood pressure increased, cardiac murmur, cardiac valve disease, electrocardiogram st segment abnormal, mitral valve disease, tricuspid valve disease. Cabergoline dosage: 4 MG (1 D),ORAL. Patient recovered.


Cabergoline Side Effects Report #4710522-1
Cabergoline side effect was reported by a Physician from ITALY on June 27, 2005. Female patient, 57 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve disease, cardiac failure, mitral valve disease. Cabergoline dosage: 2 MG (2 MG, DAILY), ORAL. During the same period patient was treated with MANTADAN, SINEMET. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4562656-2
Cabergoline side effect was reported by a Physician from on Jan 14, 2005. Female patient, 56 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve disease, fibrosis, mitral valve disease, tricuspid valve disease. Cabergoline dosage: 9 MG , ORAL. Patient recovered.

Cabergoline Side Effects Report #5161996-6
Cabergoline side effect was reported by a Physician from SPAIN on Nov 07, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac disorder, cardiac valve disease, electrocardiogram abnormal, electrocardiogram st segment depression, fibrosis, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.

Cabergoline Side Effects Report #4931009-7
Cabergoline side effect was reported by a Physician from SPAIN on Feb 14, 2006. Female patient, 49 years of age, was diagnosed with parkinson's disease , ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cardiac valve disease, electrocardiogram abnormal, electrocardiogram st segment depression, fibrosis, mitral valve disease, mitral valve incompetence, tricuspid valve incompetence. Cabergoline dosage: 5 MG, ORAL. During the same period patient was treated with PERGOLIDE, STALEVO. Patient recovered.

Cabergoline Side Effects Report #5228273-6
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.


Cabergoline Side Effects Report #5228299-2
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #5228332-8
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #5228339-0
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #5228342-0
Cabergoline side effect was reported by a Physician from AUSTRIA on Jan 19, 2007. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, cardiac valve disease, heart valve insufficiency, mitral valve disease. Cabergoline dosage: unknown. Patient recovered.

Cabergoline Side Effects Report #4575789-1
Cabergoline side effect was reported by a Physician from on Jan 24, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, blood pressure increased, dyspnoea, dyspnoea exertional, face oedema, histology abnormal, mitral valve disease, mitral valve incompetence, mitral valve prolapse. Cabergoline dosage: 8 MG, ORAL. During the same period patient was treated with ESTROGENS, MADOPAR, ACETYLSALICYLIC ACID SRT, ZUMESTON. Patient recovered.


Cabergoline Side Effects Report #4710538-5
Cabergoline side effect was reported by a Physician from GERMANY on June 27, 2005. Female patient, weighting 132.3 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: aortic valve incompetence, aortic valve sclerosis, cardiac output decreased, coronary artery atherosclerosis, dyspnoea, mitral valve disease, mitral valve incompetence, mitral valve sclerosis, pleural effusion. Cabergoline dosage: DAILY, ORAL ; 6 MG (DAILY) ORAL. During the same period patient was treated with SELEGILINE, TEBONIN, NEUROPLANT, BISOPROLOL FUMARATE, GINGIUM, FUROSEMIDE, HEPARIN. Patient was hospitalized and became disabled. Patient recovered.

Cabergoline Side Effects Report #4616929-5
Cabergoline side effect was reported by a Physician from on Mar 07, 2005. Female patient, 69 years of age, was diagnosed with ill-defined disorder and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve disease, tricuspid valve disease. Cabergoline dosage: 4 MG, ORAL. During the same period patient was treated with ATENOLOL, PHENPROCOUMON, TORSEMIDE, MACROGOL. Patient recovered.

Cabergoline Side Effects Report #5273373-8
Cabergoline side effect was reported by a Physician from SPAIN on Mar 09, 2007. Female patient, 49 years of age, was treated with Cabergoline. After drug was administered, patient experienced the following side effects: mitral valve disease, mitral valve incompetence. Cabergoline dosage: 5 MG QDAY. Patient recovered.